Krystal Biotech, Inc.
KRYS
Revenue
70.28M
▲25.03M▲55.32%
3 Months ChangeAssets
917.66M
▲64.36M▲7.54%
3 Months ChangeLiabilities
78.77M
▲24.71M▲45.72%
3 Months ChangeFree Cash Flow
14.63M
▲46.17M▲146.38%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-28
Form 8-K
ID: 0001711279-24-000045
2024-08-05
Form 10-Q
ID: 0001711279-24-000040
2024-08-05
Form 8-K
ID: 0001711279-24-000038
2024-05-21
Form 8-K
ID: 0001711279-24-000027
2024-05-08
Form 8-K
ID: 0001711279-24-000023
2024-05-06
Form 10-Q
ID: 0001711279-24-000020
2024-05-06
Form 8-K
ID: 0001711279-24-000018
2024-02-26
Form 8-K
ID: 0001711279-24-000009
2023-11-06
Form 8-K
ID: 0001711279-23-000074
2023-11-06
Form 10-Q
ID: 0001711279-23-000073